Overview of Dr. Mor
Dr. Adam Mor is a rheumatologist in New York, NY and is affiliated with multiple hospitals in the area, including NewYork-Presbyterian/Columbia University Irving Medical Center and NYC Health + Hospitals / South Brooklyn Health. He received his medical degree from Tel Aviv University Sackler and has been in practice 18 years. He is one of 21 doctors at NYC Health + Hospitals / South Brooklyn Health and one of 40 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Rheumatology. He has more than 100 publications and over 500 citings.
Office
622 West 168th Street
New York, NY 10032
Education & Training
NYU Grossman School of MedicineResidency, Internal Medicine, 2009 - 2011- NYU Grossman School of MedicineFellowship, Rheumatology, 2003 - 2005
Tel Aviv University SacklerClass of 1999
Certifications & Licensure
NY State Medical License 2011 - 2026
NJ State Medical License 2013 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- Changing the location of proteins on the cell surface is a promising strategy for modulating T cell functions.Marianne Strazza, Ruijiang Song, Shannon Hiner, Adam Mor
Immunology. 2024-10-01 - 1 citationsExclusion of PD-1 from the immune synapse: A novel strategy to modulate T cell function.Luke Yi Hao, Shalom Lerrer, Matthieu Paiola, Emily K Moore, Yevgeniya Gartshteyn
Molecular Therapy. Oncology. 2024-09-19 - An Imaging-Based Assay to Measure the Location of PD-1 at the Immune Synapse for Testing the Binding Efficacy of Anti-PD-1 and Anti-PD-L1 Antibodies.Justin C Zhong, Shalom Lerrer, Adam Mor
Bio-Protocol. 2024-09-05
Journal Articles
- Review Targeting the Programmed Cell Death-1 Pathway in Rheumatoid ArthritisAdam Mor, Greg J. Silverman, Sabina Sandigursky, ScienceDirect
Press Mentions
“Double Life” of Key Immune Protein Reveals New Strategies for Treating Cancer and Autoimmune DiseasesMarch 10th, 2024- “Double Life” of Key Immune Protein Reveals New Strategies for Treating Cancer and Autoimmune DiseasesMarch 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
